GlobalDeal

Apigenix

Biotechnology · Twann, Switzerland

apigenix.com

About Apigenix

Apigenix is a biotechnology company focused on developing innovative therapies for cancer treatment. The company specializes in the development of monoclonal antibodies and other biologics aimed at targeting specific cancer pathways. With a commitment to advancing cancer care, Apigenix leverages cutting-edge research and technology to create effective treatment options for patients. The company's lead product candidates are designed to enhance the immune response against tumors, providing new hope for patients with various types of cancer. Apigenix is dedicated to improving patient outcomes through rigorous clinical trials and collaborations with leading research institutions.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Cancer Research, Monoclonal Antibodies, Biologics, Clinical Trials
Location
Twann, Switzerland
Employees
1–10
Revenue (USD)
1–5M
Founded
2015

Products and services

Open Apigenix in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in Switzerland

All 636 Biotechnology companies in Switzerland →